Winning Stock Forecast: The Brasilian Gol Transportes Aéreos (NYSE: GOL) Brings 20.93% In 3 Days

By Gol Airlines [Public domain], via Wikimedia Commons

GOL is a young company, established in 2000, serves more then 30 million passengers annually with 67 destination and 10 countries in South America and Caribbean. Moreover, it is a leading cargo transportation and logistics business serving more than 3,400 Brazilian municipalities and, through partners, more than 200 international destinations in 95 countries.

In the end of August 2018, as part of the strategic program to renew the equipment GOL welcomed the Boeing 737MAX, the first Boieng jet in history of the company. This aircraft will

Read More

Winning ASNA Stock Forecast: Ascena Makes Major Gains Of 28.63% in 3 Days

These capabilities are key building blocks of our larger transformation roadmap to deploy and utilize an enhanced suite of merchandise planning and marketing systems. These systems will enhance our ability to compete in today’s retail environment and we will continue our aggressive rollout schedule for the next 12 to 18 months.

-David Jaffe, CEO of Ascena Retail Group Inc.

(Source: Flickr)

In only the 3 day period between May 13-16, ASNA’s stock increased by over 25%.  On May 15, the stock was trading

Read More

Winning Stock Forecast: VAALCO Energy, Inc. (NYSE: EGY) Returns up to 42.73% in 3 days

[Image Source: CERTENT]

VAALCO Energy, Inc., an independent energy company, acquires, explores for, develops, and produces crude oil and natural gas. The company holds Etame production sharing contract related to the Etame Marin block located offshore the Republic of Gabon in West Africa. It also owns interests in an undeveloped block offshore Equatorial Guinea, West Africa. VAALCO Energy, Inc. was founded in 1984 and is headquartered in Houston, Texas.

Over the 3 days after I Know First issued a bullish short term forecast for EGY on May 4, 2018, VAALCO Energy’s stock price jumped from

Read More

Winning Stock Forecast: Frontier Communications Corp (NASDAQ: FTR) Pushed Its Stock To A New Height With 39.14% In 3 Days

Winning Stock Forecast

“In the first quarter we achieved growth in consumer revenue, reflecting the early results of the substantial initiatives we have underway across the company” – Dan McCarthy, President and CEO

[Image Source: By Frontier Communications [Public domain], via Wikimedia Commons]

Over the one year period from May 2nd to May 5th, 2018 FTR stock price experienced steep price rise of more than 39%. Taking into account the overall FTR stock performance indicators for the last quarter, it is reasonable to suggest that this is the consequence of the company’s results achieved in 1Q 2018

Read More

Winning Stock Forecast: DMC (NASDAQ: BOOM) Is Booming With 25.92% In 3 Days

Winning Stock Forecast

“North America’s unconventional onshore oil and gas industry remains very active, and a growing number of operators and service companies are turning to these systems to enhance well-completion efficiencies, improve reliability and drive down operating costs.” – Kevin Longe, president and CEO

Over the 3 days period starting from April 26, 2018, DMC’s stock price experienced steep price rise of more than 25%. Taking into account the overall BOOM stock performance of +200% over the trailing year , it is reasonable to suggest that this is the result of the company’s

Read More

Quick Win by the Algorithm: Geron Corporation (NASDAQ: GERN) Treats Investors With Stock Up 24.71% In 3 Days

Quick Algorithm

“With the preliminary data from IMerge presented at ASH, we now have clinical data in three blood cancers, ET, MF and MDS, where imetelstat exhibits potential disease modifying activity by inhibiting the progenitor cells of the malignant clones that drive the underlying diseases”

– said John A. Scarlett, M.D., Geron’s President and Chief Executive Officer.

(Image Source: www.troutaccess.com)

Geron Corporation (NASDAQ: GERN) operates as a biopharmaceutical company. The company supports the clinical stage development of imetelstat, a telomerase inhibitor for the

Read More